Search Ontology:
ChEBI
ponatinib
- Term ID
- CHEBI:78543
- Synonyms
-
- 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide
- AP 24534
- AP-24534
- AP24534
- ponatinib
- ponatinibum
- Definition
- A benzamide obtained by the formal condensation of the carboxy group of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methylbenzoic acid with the anilino group of 4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)aniline. It is a multi-target tyrosine kinase inhibitor that targets ABL, SRC, FGFR, and others and was designed to overcome the resistance of BCR-ABL mutation to imatinib, in particular the gatekeeper mutation ABL(T315I).
- References
-
- CAS:943319-70-8
- DrugBank:DB08901
- Drug_Central:4716
- HMDB:HMDB0240214
- KEGG:D09950
- LINCS:LSM-1151
- PMCID:PMC8895737
- PMID:24297701
- PMID:24402926
- PMID:24407160
- PMID:24408322
- PMID:24472312
- PMID:24481648
- PMID:24550512
- PMID:24552773
- PMID:24586514
- PMID:24596204
- PMID:24602068
- PMID:24695735
- PMID:24729118
- PMID:24756787
- PMID:24766374
- PMID:24768818
- PMID:24807266
- PMID:24934866
- PMID:30417093
- PMID:33929369
- PMID:34406581
- PMID:34649276
- PMID:34821935
- PMID:34871094
- PMID:34885009
- PMID:34939982
- PMID:34984405
- PMID:34987886
- PMID:35059859
- PMID:35091442
- PMID:35091541
- PMID:35122387
- PMID:35151199
- PMID:35325305
- PMID:35332794
- PMID:35338182
- PMID:35349077
- PMID:35411096
- PMID:35412404
- PMID:35544670
- Patent:US2014038920
- Reaxys:12923700
- Wikipedia:Ponatinib
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
- inverse is_conjugate_acid_of
-
- is_conjugate_base_of
-
Phenotype
Phenotype resulting from ponatinib
Phenotype where environments contain ponatinib
Phenotype modified by environments containing ponatinib
Human Disease Model